JP2013507907A5 - - Google Patents

Download PDF

Info

Publication number
JP2013507907A5
JP2013507907A5 JP2012533696A JP2012533696A JP2013507907A5 JP 2013507907 A5 JP2013507907 A5 JP 2013507907A5 JP 2012533696 A JP2012533696 A JP 2012533696A JP 2012533696 A JP2012533696 A JP 2012533696A JP 2013507907 A5 JP2013507907 A5 JP 2013507907A5
Authority
JP
Japan
Prior art keywords
fusion protein
domain
vector
polynucleotide sequence
acid sequence
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2012533696A
Other languages
English (en)
Japanese (ja)
Other versions
JP2013507907A (ja
Filing date
Publication date
Priority claimed from GBGB0918154.6A external-priority patent/GB0918154D0/en
Application filed filed Critical
Publication of JP2013507907A publication Critical patent/JP2013507907A/ja
Publication of JP2013507907A5 publication Critical patent/JP2013507907A5/ja
Pending legal-status Critical Current

Links

JP2012533696A 2009-10-16 2010-10-15 マイコバクテリアワクチン Pending JP2013507907A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB0918154.6A GB0918154D0 (en) 2009-10-16 2009-10-16 Mycobacterial vaccines
GB0918154.6 2009-10-16
PCT/GB2010/051741 WO2011045612A1 (en) 2009-10-16 2010-10-15 Mycobacterial vaccines

Publications (2)

Publication Number Publication Date
JP2013507907A JP2013507907A (ja) 2013-03-07
JP2013507907A5 true JP2013507907A5 (https=) 2013-11-28

Family

ID=41462453

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2012533696A Pending JP2013507907A (ja) 2009-10-16 2010-10-15 マイコバクテリアワクチン

Country Status (14)

Country Link
US (1) US9181311B2 (https=)
EP (1) EP2488549B1 (https=)
JP (1) JP2013507907A (https=)
KR (1) KR20120083899A (https=)
CN (1) CN102666575B (https=)
AU (1) AU2010308120B2 (https=)
BR (1) BR112012008790A2 (https=)
CA (1) CA2776001A1 (https=)
EA (1) EA201270517A1 (https=)
GB (1) GB0918154D0 (https=)
NZ (1) NZ599259A (https=)
PH (1) PH12012500849A1 (https=)
WO (1) WO2011045612A1 (https=)
ZA (1) ZA201202363B (https=)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201006405D0 (en) 2010-04-16 2010-06-02 Isis Innovation Poxvirus expression system
EP2812704A4 (en) * 2012-02-07 2016-03-23 Intuitive Biosciences Inc MYCOBACTERIUM STUBERCULOSIS-SPECIFIC PEPTIDES FOR DETECTING INFECTION OR IMMUNIZATION OF NON-MUSCLE PRIMATES
CN104640564B (zh) * 2012-07-10 2020-08-04 特兰斯吉恩股份有限公司 分枝杆菌抗原疫苗
AU2013357367B2 (en) 2012-12-11 2019-10-24 Osivax Sas Modified coiled coil type proteins having improved properties
EP2976357B1 (en) 2013-03-18 2018-10-17 Osivax SAS Influenza nucleoprotein vaccines
CN103290053A (zh) * 2013-05-17 2013-09-11 中国人民解放军第四军医大学 唾液腺导管细胞特异性启动子的腺病毒载体及其构建方法
CN105431166B (zh) * 2013-06-25 2020-09-18 国际艾滋病疫苗行动组织公司 结核病组合物和其使用方法
US10226522B2 (en) 2013-08-30 2019-03-12 Globeimmune, Inc. Compositions and methods for the treatment or prevention of tuberculosis
CN106029870A (zh) * 2014-01-16 2016-10-12 凯利斯塔公司 用于增强的氨基酸产生的微生物及相关方法
CN104805063A (zh) * 2014-01-24 2015-07-29 中国人民解放军第三〇九医院 结核分枝杆菌潜伏感染相关蛋白及其制备和应用
US10406218B2 (en) 2014-04-09 2019-09-10 La Jolla Institute For Allergy And Immunology Specific and unique T cell responses and molecular signatures for the treatment and diagnosis of Mycobacterium tuberculosis
CN107076744B (zh) * 2014-08-29 2021-01-19 国家科研中心 用于诊断潜伏性感染的结核分枝杆菌的组合物
WO2016154422A1 (en) 2015-03-24 2016-09-29 Fred Hutchinson Cancer Research Center Engineered and multimerized human immunodeficiency virus envelope glycoproteins and uses thereof
CN106237317A (zh) * 2015-06-15 2016-12-21 复旦大学 由结核分枝杆菌抗原组成的结核疫苗
GB201513176D0 (en) * 2015-07-27 2015-09-09 Glaxosmithkline Biolog Sa Novel methods for inducing an immune response
US10428122B2 (en) 2016-06-16 2019-10-01 International Aids Vaccine Initiative, Inc. Tuberculosis compositions and methods of treating or preventing tuberculosis
CN108239660B (zh) * 2016-12-26 2021-08-10 上海生物制品研究所有限责任公司 一种重组结核病疫苗,其制备方法及应用
MX2019013259A (es) 2017-05-08 2020-01-13 Gritstone Oncology Inc Vectores de neoantigeno de alfavirus.
US11591375B2 (en) * 2018-01-22 2023-02-28 Oregon State University Immunogenic compositions comprising Mycobacterium bovis surface proteins and uses thereof
MX2021014525A (es) 2019-05-30 2022-03-17 Gritstone Bio Inc Adenovirus modificados.
CN110240637A (zh) * 2019-06-04 2019-09-17 华中农业大学 牛分枝杆菌免疫相关的分子伴侣蛋白GroEL2及其编码基因与应用
KR102193304B1 (ko) * 2019-10-24 2020-12-22 충남대학교산학협력단 Rv2299c-ESAT6-HspX-RipA 융합단백질의 BCG 백신 booster용 조성물
CN110724182B (zh) * 2019-11-15 2022-04-08 上海交通大学 提高菌阴结核感染检测敏感性的标志物组合及应用
WO2021119545A1 (en) * 2019-12-11 2021-06-17 Gritstone Bio, Inc. Durable vaccination
KR20230046313A (ko) 2020-08-06 2023-04-05 그릿스톤 바이오, 인코포레이티드 다중에피토프 백신 카세트
CN112979825A (zh) * 2021-02-04 2021-06-18 兰州大学 结核分枝杆菌融合蛋白lt29构建及其表达纯化方法和应用
CN113999865B (zh) * 2021-10-09 2023-06-16 安徽理工大学 结核分枝杆菌融合蛋白ar2及其构建与表达纯化方法和应用
CN115920003B (zh) * 2022-08-31 2024-11-29 中国医学科学院病原生物学研究所 脂蛋白LprG及其基因作为抗结核分枝杆菌药物靶点的应用
CN116041543B (zh) * 2022-12-07 2023-12-26 中国疾病预防控制中心传染病预防控制所 结核分枝杆菌多抗原融合蛋白及其编码基因和应用

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0465633A1 (en) * 1990-01-26 1992-01-15 Biogen, Inc. C4 binding protein fusion proteins
CN1284854C (zh) * 2003-03-06 2006-11-15 钟森 用于预防结核病和免疫治疗的嵌合型dna疫苗
CN1867588A (zh) 2003-08-12 2006-11-22 阿维迪斯公司 包含c4bp核心蛋白质和单体抗原的产品及其用途
EP1957528B1 (en) * 2005-11-30 2012-11-07 University of Copenhagen A nucleotide vaccine
EP1795540A1 (en) * 2005-11-30 2007-06-13 Imaxio Multimeric complexes of antigens and an adjuvant
GB0706912D0 (en) 2007-04-10 2007-05-16 Isis Innovation Novel viral vaccines
CN101428143B (zh) * 2008-12-09 2011-05-11 武汉大学 携带结核基因的减毒细菌载体结核疫苗及制备方法和应用

Similar Documents

Publication Publication Date Title
JP2013507907A5 (https=)
JP2014534202A5 (https=)
JP2008529558A5 (https=)
JP2008530245A5 (https=)
JP2010500399A5 (https=)
JP2019526580A5 (https=)
JP2015533841A5 (https=)
JP2017122120A5 (https=)
JP2015524794A5 (https=)
CN111533812B (zh) 针对sars-cov-2病毒的dna疫苗及其用途
JP2012524733A5 (https=)
JP2016539946A5 (https=)
JP2012515557A5 (https=)
JP2019506175A5 (https=)
RU2014144133A (ru) Простатоассоциированные антигены и иммунотерапевтические схемы на основе вакцин
JP2008539187A5 (https=)
JP2015509707A5 (https=)
JP2014507146A5 (https=)
JP2017505605A5 (https=)
JP2018528237A5 (https=)
CN111655281A (zh) 用于结核病的含环二核苷酸佐剂的疫苗的鼻内递送
JP7146926B2 (ja) Cd4ヘルパーt細胞エピトープの融合ペプチドおよびそのワクチン
JP2016106117A5 (https=)
JP2019534884A5 (https=)
JP2012102105A5 (https=)